Methylphenidate Transdermal Patch and Rasagiline: Interaction Details
- Rasagiline
- Azilect
- Methylphenidate Transdermal Patch
- DaytranaMethylinMetadate +8 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Methylphenidate Transdermal Patch and Rasagiline interaction:
Methylphenidate Transdermal Patch
- Daytrana
- Methylin
- Metadate
- Ritalin
- Concerta
- Quillivant
- Aptensio
- QuilliChew
- Cotempla
- Relexxii
- Jornay
What Happens When You Take Methylphenidate Transdermal Patch With Rasagiline
What can happen when they are taken together (rated Contraindicated)
An increased risk of (headache, palpitation, and neck stiffness)
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Giving methylphenidate together with can precipitate a hypertensive crisis. The possible consequences include death, stroke, myocardial infarction, aortic dissection, ophthalmological complications, eclampsia, pulmonary edema, and failure. For this reason, methylphenidate is during therapy and for 14 days after an MAOI has been stopped.3124
The Methylphenidate Transdermal Patch and Rasagiline Interaction, Explained
Rasagiline (Azilect) is used for Parkinson's disease, and the Daytrana patch delivers methylphenidate, a stimulant used for ADHD. Taking them together can cause a sudden, dangerous spike in blood pressure (a ). Warning signs include a severe headache, a pounding or racing heartbeat, and a stiff neck.
The labeling lists this combination as , which also applies for 14 days after stopping rasagiline. Researchers consider the risk largely theoretical, but the possible results are serious, so it is taken very seriously. Please don't stop or start anything on your own. Talk with your pharmacist or doctor, who can review your options and keep you safe.
Interaction: Rasagiline (irreversible MAO-B , with loss of selectivity at higher doses) plus methylphenidate (transdermal; DAT/NET reuptake inhibitor that increases catecholamine release) may precipitate via potentiated adrenergic/pressor effects. The mechanism is listed as unknown, and evidence is theoretical. Neither drug is a in a way that alters this interpretation.
- Onset: rapid.
- Severity: per labeling (methylphenidate with or within 14 days of discontinuation).
- Outcomes: stroke, MI, aortic dissection, ophthalmic complications, eclampsia, pulmonary edema, failure, death.
- Management: avoid the combination; consider alternatives. Observe the 14-day washout after the MAOI. Counsel on headache, palpitations, and neck stiffness, and seek urgent care if they occur.
See the 4 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Methylphenidate Transdermal Patch and Rasagiline Interact
The likely mechanism
Unknown
“Unknown” here means the studies and labels behind this record do not say how the interaction happens. It does not mean the interaction is unlikely.
When two medicines can each cause the same effect, here effects on the heart’s rhythm, taking them together can add to it. That is often the reason for an interaction like this one, though the sources do not confirm it for this pair.
How to Manage the Methylphenidate Transdermal Patch and Rasagiline Interaction
The documented guidance is to avoid this combination, including within 14 days after stopping rasagiline. Your care team will typically look at alternative treatments rather than adjusting doses.
- Don't start, stop, or change either medicine on your own. Ask your prescriber or pharmacist first.
- Tell every prescriber and pharmacy that you use rasagiline and the methylphenidate patch.
- If a switch is planned, your team can advise on the timing of the 14-day gap.
- Seek urgent medical help for a severe headache, pounding heartbeat, or neck stiffness.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Methylphenidate Transdermal Patch or Rasagiline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Methylphenidate Transdermal Patch and Rasagiline: Common Questions
How serious is the Methylphenidate Transdermal Patch and Rasagiline interaction?
It is rated . These should generally not be used together.
How is the Methylphenidate Transdermal Patch and Rasagiline interaction managed?
The documented guidance is to avoid this combination, including within 14 days after stopping rasagiline. Your care team will typically look at alternative treatments rather than adjusting doses. Don't start, stop, or change either medicine on your own. Ask your prescriber or pharmacist first. Tell every prescriber and pharmacy that you use rasagiline and the methylphenidate patch. If a switch is… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Methylphenidate Transdermal Patch and Rasagiline Interaction
Ask in your own words about taking Methylphenidate Transdermal Patch and Rasagiline together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (4)
- Product Information: COTEMPLA XR-ODT oral extended-release disintegrating tablets, methylphenidate oral extended-release disintegrating tablets. Neos Therapeutics Inc (per FDA), Grand Prairie, TX, 2023. DailyMed
- Product Information: DAYTRANA(R) transdermal system, methylphenidate transdermal system. Noven Therapeutics LLC (per FDA), Miami, FL, 2023. DailyMed
- Product Information: JORNAY PM(R) oral extended-release capsules, methylphenidate hydrochloride oral extended-release capsules. Ironshore Pharmaceuticals Inc (per FDA), Morrisville, NC, 2023. DailyMed
- Product Information: Ritalin LA(R) oral extended-release capsules, methylphenidate HCl oral extended-release capsules. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2019. DailyMed
Other Serious Interactions of Methylphenidate Transdermal Patch and Rasagiline
Also serious with Rasagiline
- Acetaminophen and CodeineContraindicated
- SertralineContraindicated
- DeutetrabenazineContraindicated
- DiethylpropionContraindicated
Also serious with Methylphenidate Transdermal Patch
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Rasagiline
- YohimbeMajor
- Activated CharcoalMajor
- SoyMajor
- CowhageMajor
- Bitter OrangeMajor
- WineMajor
- BeerMajor
- Brewer's YeastMajor
- + 168 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together. This interaction.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.